Colton Groome Financial Advisors LLC Makes New Investment in Danaher Corporation $DHR

Colton Groome Financial Advisors LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 2,674 shares of the conglomerate’s stock, valued at approximately $592,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Studio Investment Management LLC raised its position in Danaher by 3.3% during the second quarter. Studio Investment Management LLC now owns 1,581 shares of the conglomerate’s stock valued at $302,000 after purchasing an additional 51 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in shares of Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the last quarter. JDH Wealth Management LLC increased its position in shares of Danaher by 4.5% during the 1st quarter. JDH Wealth Management LLC now owns 1,264 shares of the conglomerate’s stock valued at $240,000 after purchasing an additional 55 shares during the last quarter. OneAscent Financial Services LLC raised its holdings in shares of Danaher by 5.5% during the 4th quarter. OneAscent Financial Services LLC now owns 1,069 shares of the conglomerate’s stock valued at $245,000 after buying an additional 56 shares in the last quarter. Finally, Syon Capital LLC lifted its position in Danaher by 0.8% in the 4th quarter. Syon Capital LLC now owns 6,954 shares of the conglomerate’s stock worth $1,592,000 after buying an additional 57 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Trading Down 1.6%

Danaher stock traded down $3.48 during trading hours on Tuesday, reaching $217.73. The stock had a trading volume of 1,774,393 shares, compared to its average volume of 4,452,227. The company has a fifty day simple moving average of $209.69 and a 200-day simple moving average of $193.88. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The stock has a market cap of $153.06 billion, a PE ratio of 38.67, a PEG ratio of 2.67 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.77 earnings per share. Analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a $0.40 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is 28.42%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on DHR shares. Stifel Nicolaus reduced their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Wells Fargo & Company reduced their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Finally, Piper Sandler assumed coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $234.09.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.